---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-030579"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:34:36.397507+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Biohaven establishes $350M at-the-market equity offering via amended agreement with J.P. Morgan

## Summary
- Amendment No. 2 to Equity Distribution Agreement allows up to $350M in common share sales.
- J.P. Morgan Securities acts as manager for ATM program on NYSE at prevailing market prices.
- New shelf registration (File No. 333-295531) and prospectus supplement filed May 4, 2026.
- Proceeds for general corporate purposes; timing and amount depend on market conditions.

## SEC filing metadata
- accession: 0001628280-26-030579
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000162828026030579/0001628280-26-030579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000162828026030579/bhvn-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-030579
- JSON: https://secwatch.observer/filing/0001628280-26-030579.json
- Plain text: https://secwatch.observer/filing/0001628280-26-030579.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
